Français Log in Book a call

Resources

Selling to hospitals, at the right moment.

Tenders, accreditations, public registries: where hospitals announce what they’re buying, and how to turn that into a first meeting. Sources included.

Featured

Where to start

Library

All articles

  • Buying signals

    Signal-based personalization in 2026: it’s not a merge field

    A first name dropped into a template is still a template: across more than 20 million emails, Woodpecker measures a 17 to 18% reply rate for messages built on a real event at the prospect, versus 7 to 9% for merge fields alone. A campaign built on individual signals reached a 64.7% read rate on 797 messages sent to radiologists in six countries. Here’s what separates the two approaches.

    9 min read

  • Outbound

    Prospect database size: a vanity metric in 2026

    A large prospect database predicts no sales. In a 2025 Validity report (n=602), 76% of CRM teams say less than half of their data is accurate, and an exclusion method (scrape broadly, then disqualify tightly) turns a dormant file into a list that converts, as a French MedTech company showed by keeping only a minority of qualified profiles. What predicts a sale is the signal isolated within the database, not its volume.

    7 min read

  • Outbound

    Prospecting ROI in 2026: measure budget, not leads

    Counting leads predicts no sales: in a lead-centric process, fewer than 1% of contacts end up as signed deals (Forrester). The only number that matters is the sales budget redeployed toward prospects with an active signal, and the pipeline that fills up behind it. Here’s how to measure prospecting in sales time recovered and meetings booked, not in volume.

    7 min read

  • Outbound

    Cold email in 2026: spray-and-pray is dead, not the channel

    Cold email isn’t dead in 2026: in B2B, GDPR allows it on the basis of legitimate interest, and targeted campaigns get reply rates of 5.5% to 10.7% while the average stalls at 3.43%. What’s dying is spray-and-pray, the undifferentiated mass sending that burns your sender reputation. Here’s how signal-based targeting keeps the channel alive.

    8 min read

  • Buying signals

    B2B buying intent: you won’t find it on LinkedIn

    On LinkedIn, Buyer Intent measures reactions, profile views, and page visits, not the decision to buy. Real intent leaves a public trace elsewhere: a tender, an authorization, a new company registration, an expiring certification. Nearly 200,000 public contracts a year on BOAMP alone prove it. Here’s where B2B buying intent really lives, and how to detect it.

    8 min read

  • Outbound

    AI SDRs: why mass sending fails in 2026

    Mass-sending AI SDRs are hitting a ceiling: Gartner expects more than 40% of agentic AI projects to be scrapped by the end of 2027, and undifferentiated cold email stalls at 1 to 5% replies. What drives replies is detecting a public buying signal before you reach out, not volume. How signal-based sorting replaces spray-and-pray.

    8 min read

  • Outbound

    How to activate a dormant lead database: the 2026 method

    Hundreds of contacts sitting dormant in a file lose nearly 30% of their value a year. Here’s how to re-enrich them, spot recent buying signals, and relaunch targeted outreach in three weeks, without buying a new database or hiring, with Agify.

    7 min read

  • Outbound

    How to personalize 500 cold emails a day without sounding like a bot

    Sending 500 cold emails a day without landing in spam comes down to one choice: not personalizing them all to the same level. The 4-tier system allocates effort by account value, from mass messaging to hyper-personalization. The method, the ratios, and the workflow.

    9 min read

  • Public data

    MedTech regulatory signals in 2026: invisible to Apollo

    EUDAMED, ANSM notifications, and CE marking show that a medical device is moving from development to sale, months before LinkedIn does. Horizontal B2B databases don’t read these regulatory registries. How to turn this public calendar into an actionable buying signal, right where Apollo is blind.

    8 min read

  • Healthcare market

    100% phone coverage in healthcare: the GDPR dead end (2026)

    No healthcare prospecting list reaches 100% phone coverage without scraping or buying lists, two practices the CNIL sanctions. With compliant public sources, phone coverage caps out at around 30 to 40%. Here’s why 100% is a sign of non-compliance.

    8 min read

  • Healthcare market

    Apollo, Lusha, ZoomInfo: the hospital data they miss in 2026

    Apollo, ZoomInfo, and Lusha sell volumes of static contacts: 230 to 321 million names whose accuracy drops in Europe. None of them reads the public buying signals of the French hospital market (BOAMP, ARS, HAS, RPPS, EUDAMED). A name without context or timing isn’t enough to sell to a hospital.

    7 min read

  • Public data

    IAF CertSearch: the buying signal for ISO-certified mid-market companies in 2026

    IAF CertSearch is the global public database of accredited ISO certifications. For an industrial supplier, it’s the only buying signal you can plan for by design: an ISO certification runs on a three-year cycle, so the renewal audit, and the window of need that comes with it, can be worked out months in advance. The real question is what that audit reveals about a mid-market manufacturer’s needs.

    10 min read

  • Healthcare market

    Medical leads across 18 countries: 10,000 qualified in 8 days (2026)

    The EU has 1.98 million doctors and no shared central registry. A French medical imaging MedTech built more than 10,000 qualified contacts across 18 European countries in 8 days, organized into 4 distinct groups it can reuse for every campaign of the year.

    10 min read

  • Outbound

    Generic cold email: why it died in 2026

    Cold email isn’t dead; generic cold email is. Generative AI made surface personalization free, and therefore worthless, and overloaded the spam filters. What converts now is the buying signal, not the formula.

    7 min read

  • Public data

    The RPPS: France’s MedTech targeting engine in 2026

    The RPPS lists every healthcare professional in France. For a MedTech team, it isn’t a directory: it’s a targeting engine that segments a market by specialty, facility, and region, where Apollo and Sales Navigator have no data at all.

    8 min read

  • Public data

    HAS data: 4,342 clinics mapped and targeted in 9 days (2026)

    France’s National Authority for Health (HAS) publishes quality data on more than 4,300 facilities. A French healthcare messaging platform had 4,342 clinics mapped and 9,000 decision-makers qualified in 9 days to equip its sales reps.

    8 min read

  • Healthcare market

    Sales Navigator in MedTech: the missing signal (2026)

    Sales Navigator identifies who exists, and its Buyer Intent reads LinkedIn activity. But it misses the public MedTech buying signals (BOAMP, ARS, HAS) that date the buying window.

    9 min read

  • Public data

    HAS certification: the buying signal your CRM misses

    French hospitals’ HAS certification and IQSS scores are public. A facility certified with conditions revisits its quality priorities within 6 to 24 months: a buying window that Apollo and Sales Navigator can’t see.

    8 min read

  • Healthcare market

    MedTech case study: qualified radiologists in 6 weeks

    A French medical imaging company qualified a database of European radiologists in six weeks by cross-referencing more than ten public healthcare sources. The method, the numbers, and the CRM cleanup.

    8 min read

Get our notes from the field.

What we see with our customers: the signals that mattered, the messages that got a reply, the mistakes to avoid. Every other Tuesday, once the English edition launches. Unsubscribe in one click.

Subscribe

Choose what you accept, purpose by purpose. Your choice is kept on this device for six months, after which we will ask again.

  • Strictly necessary

    These store your cookie choices. They serve no other purpose and can’t be turned off.

    Always on

  • Remembers where your visit came from (search engine, social network, campaign) for the length of the visit, and the first source we know of for up to 13 months, so we can tell which channels bring in requests. This information is attached to any request you send us. No advertising, no tracking on other websites.